Trial site
The Research Institute of the McGill University
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers2 trials
- Head and neck cancer2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Hodgkin lymphoma1 trial
- Kidney cancer1 trial
- Mesothelioma1 trial
- Multiple myeloma1 trial
- Sarcoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 28 trials
- Phase 34 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Completed5 trials
- Recruiting5 trials
- Active, not recruiting4 trials
- Lead sponsor
- Canadian Cancer Trials Group14 trials
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma2 recruiting
- Childhood cancers1 recruiting
- Hodgkin lymphoma1 recruiting
- Kidney cancer1 recruiting
- Multiple myeloma1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Completed
Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours
Completed
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Site data: ClinicalTrials.govUpdated 17 Nov 2026